Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Poor Outcome after Allogeneic Hematopoietic Stem Cell Transplantation for De Novo AML with Chromosome 7 Abnormalities: A Report for the ALWP of the European Group for Blood and Marrow Transplantation.

Agnes Buzyn, MD, PhD, Myriam Labopin, MD, Jurgen Finke, MD, Tapani Ruutu, MD, G. Ehninger, MD, Leo F. Verdonck, MD, Gerard Socie, MD, PhD, Roelof Willemze, MD, Karel Indrak, MD, Nigel H. Russell, MD, Vanderson Rocha, for the ALWP of the EBMT

Blood (2007) 110 (11): 325.

https://doi.org/10.1182/blood.V110.11.325.325

Published: 2007

Journal Articles

Clinical Course and Significance of the Novel FLT3-Y842C Mutation in a Patient with AML Treated with PKC412 Monotherapy.

T. Kindler, F. Breitenbuecher, S. Kasper, E. Estey, F. Giles, E. Feldman, G. Ehninger, G. Schiller, V. Klimek, S. D. Nimer, A. Gratwohl, C. Choudhary, C. Mueller-Tidow, H. Serve, H. Gschaidmeier, P. S. Cohen, C. Huber, T. Fischer

Blood (2004) 104 (11): 2537.

https://doi.org/10.1182/blood.V104.11.2537.2537

Published: 2004

Journal Articles

Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML.

F. Heidel, F. Breitenbuecher, T. Kindler, F. K. Solem, B. Carius, H.-M. Thiede, P. S. Cohen, J. Roesel, E. H. Estey, E. Feldman, G. Ehninger, G. J. Schiller, V. Klimek, S. Nimer, D. DeAngelo, F. Giles, R. M. Stone, C. Huber, T. Fischer

Blood (2004) 104 (11): 454.

https://doi.org/10.1182/blood.V104.11.454.454

Published: 2004

Journal Articles

Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.

Martin C. Mueller, MD, P. Paschka, MD, T. Lahaye, MD, Ch. Lorentz, MD, N. Gattermann, MD, D. Niederwieser, MD, G. Ehninger, MD, St Fruehauf, MD, A. Neubauer, MD, Th. Fischer, MD, B. Schultheis, MD, S. Kreil, MD, U. Haus, PhD, R. Hehlmann, MD, A. Hochhaus, MD, the German CML Study Group

Blood (2004) 104 (11): 1003.

https://doi.org/10.1182/blood.V104.11.1003.1003

Published: 2004

Journal Articles

Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation

O. Ringdén, M. Remberger, V. Runde, M. Bornhäuser, I.W. Blau, N. Basara, K. Hölig, D.W. Beelen, H. Hägglund, O. Basu, G. Ehninger, A.A. Fauser

Blood (1999) 94 (2): 455–464.

https://doi.org/10.1182/blood.V94.2.455

Published: 1999

Journal Articles

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

H Einsele, G Ehninger, H Hebart, KM Wittkowski, U Schuler, G Jahn, P Mackes, M Herter, T Klingebiel, J Loffler

Blood (1995) 86 (7): 2815–2820.

https://doi.org/10.1182/blood.V86.7.2815.2815

Published: 1995

Journal Articles

Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine model

G Ehninger, U Schuler, U Renner, M Ehrsam, KP Zeller, J Blanz, R Storb, HJ Deeg

Blood (1995) 85 (11): 3247–3249.

https://doi.org/10.1182/blood.V85.11.3247.bloodjournal85113247

Published: 1995

Journal Articles

Questions about the role of granulocyte-macrophage colony-stimulating factor as adjunct to non-Hodgkin's lymphoma chemotherapy [letter; comment]

US Schuler, G Ehninger, R Ludtke

Blood (1994) 84 (5): 1691–1692.

https://doi.org/10.1182/blood.V84.5.1691.1691

Published: 1994

Journal Articles

Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation

H Einsele, G Ehninger, M Steidle, I Fischer, S Bihler, F Gerneth, A Vallbracht, H Schmidt, HD Waller, CA Muller

Blood (1993) 82 (5): 1672–1678.

https://doi.org/10.1182/blood.V82.5.1672.1672

Published: 1993

Journal Articles

Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study

R Dopfer, G Henze, C Bender-Gotze, W Ebell, G Ehninger, W Friedrich, H Gadner, T Klingebiel, C Peters, H Riehm

Blood (1991) 78 (10): 2780–2784.

https://doi.org/10.1182/blood.V78.10.2780.2780

Published: 1991

Journal Articles

Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique

H Einsele, M Steidle, A Vallbracht, JG Saal, G Ehninger, CA Muller

Blood (1991) 77 (5): 1104–1110.

https://doi.org/10.1182/blood.V77.5.1104.1104

Published: 1991

NARROW

Poor Outcome after Allogeneic Hematopoietic Stem Cell Transplantation for De Novo AML with Chromosome 7 Abnormalities: A Report for the ALWP of the European Group for Blood and Marrow Transplantation.

Clinical Course and Significance of the Novel FLT3-Y842C Mutation in a Patient with AML Treated with PKC412 Monotherapy.

Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML.

Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.

Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine model

Questions about the role of granulocyte-macrophage colony-stimulating factor as adjunct to non-Hodgkin's lymphoma chemotherapy [letter; comment]

Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation

Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study

Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only